IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Protagonist Therapeutics Inc

CUSIP: 4366E1029 | 1 institutional holders

Quarters

Q3 2019Q2 2019Q1 2019Q4 2018Q3 2018
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q3 2019

Perceptive Advisors LLC2,071,297
0.0% of portfolio›$24.9K
StyleTurnoverLocationFiled
Perceptive Advisors LLC
2,071,297$24.9K0.0%CoreHighNew York, NY2019-11-14